Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -20.00%112 | -20.00%112 | -20.45%560 | -20.45%140 | -20.45%140 | -20.45%140 | -20.45%140 | -20.36%704 | -20.36%176 | -20.36%176 |
| Gross profit | 20.00%-112 | 20.00%-112 | 20.45%-560 | 20.45%-140 | 20.45%-140 | 20.45%-140 | 20.45%-140 | 20.36%-704 | 20.36%-176 | 20.36%-176 |
| Operating expense | 129.59%554.53K | 17.20%159.64K | -41.50%761.8K | -71.34%125.11K | 87.57%258.96K | -56.12%241.53K | -23.11%136.21K | 84.15%1.3M | 154.37%436.52K | -9.20%138.06K |
| Selling and administrative expenses | 129.59%554.53K | 17.20%159.64K | -41.50%761.8K | -71.34%125.11K | 87.57%258.96K | -56.12%241.53K | -23.11%136.21K | 84.60%1.3M | 154.37%436.52K | -9.20%138.06K |
| -General and administrative expense | 129.59%554.53K | 17.20%159.64K | -41.50%761.8K | -71.34%125.11K | 87.57%258.96K | -56.12%241.53K | -23.11%136.21K | 84.60%1.3M | 154.37%436.52K | -9.20%138.06K |
| Operating profit | -129.50%-554.64K | -17.16%-159.76K | 41.48%-762.36K | 71.32%-125.25K | -87.43%-259.1K | 56.11%-241.67K | 23.11%-136.35K | -84.02%-1.3M | -154.15%-436.69K | 9.21%-138.24K |
| Net non-operating interest income (expenses) | -516.85%-549 | -1,377.78%-133 | 43.38%-389 | -45.76%-86 | -365.91%-205 | 85.55%-89 | 47.06%-9 | -75.26%-687 | 89.19%-59 | -109.61%-44 |
| Non-operating interest income | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| Non-operating interest expense | 516.85%549 | 1,377.78%133 | -43.38%389 | 681.82%86 | 365.91%205 | -85.55%89 | -47.06%9 | 75.26%687 | 22.22%11 | -44.30%44 |
| Other net income (expenses) | -75.38%40K | -6,539.30%-8.58M | -1,296.91%-8.85M | -76.52%81.41K | 275.55%162.46K | -81.44%21.17K | 77.60%-129.24K | -0.47%-633.24K | 651.28%346.75K | |
| Gain on sale of security | --40K | ---- | ---20K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | ---- | ---- | -2,282.79%-8.83M | ---- | ---- | ---- | ---- | 41.75%-370.4K | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | 2,267.86%8.77M | ---- | ---- | ---- | ---- | -41.75%370.4K | ---- | ---- |
| -Less:Write off | ---- | ---- | --55.33K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | 9.90%265.04K | --0 | -76.52%81.41K | 275.55%162.46K | -81.44%21.17K | 308.93%241.16K | -4,804.56%-262.84K | 651.28%346.75K |
| Income before tax | -549.67%-515.19K | -38.80%-159.89K | -552.14%-9.34M | -738.43%-8.97M | -185.33%-177.89K | 84.39%-79.3K | -81.98%-115.19K | -11.48%-1.43M | -33.31%-1.07M | 297.31%208.46K |
| Income tax | -280.39%-1.05M | 425.99%581.97K | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -549.67%-515.19K | -38.80%-159.89K | -311.66%-8.29M | -379.51%-7.92M | -185.33%-177.89K | 84.39%-79.3K | -81.98%-115.19K | -82.05%-2.01M | -164.69%-1.65M | 297.31%208.46K |
| Net income continuous operations | -549.67%-515.19K | -38.80%-159.89K | -311.66%-8.29M | -379.51%-7.92M | -185.33%-177.89K | 84.39%-79.3K | -81.98%-115.19K | -82.05%-2.01M | -164.69%-1.65M | 297.31%208.46K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -549.67%-515.19K | -38.80%-159.89K | -311.66%-8.29M | -379.51%-7.92M | -185.33%-177.89K | 84.39%-79.3K | -81.98%-115.19K | -82.05%-2.01M | -164.69%-1.65M | 297.31%208.46K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -549.67%-515.19K | -38.80%-159.89K | -311.66%-8.29M | -379.51%-7.92M | -185.33%-177.89K | 84.39%-79.3K | -81.98%-115.19K | -82.05%-2.01M | -164.69%-1.65M | 297.31%208.46K |
| Diluted earnings per share | 0 | 0 | -250.00%-0.07 | -250.00%-0.07 | 0 | 0 | 0 | 0.00%-0.02 | -100.00%-0.02 | 0 |
| Basic earnings per share | 0 | 0 | -250.00%-0.07 | -250.00%-0.07 | 0 | 0 | 0 | 0.00%-0.02 | -100.00%-0.02 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.